The 5 analysts offering 12-month price forecasts for Milestone Pharmaceuticals Inc have a median target of 13.00, with a high estimate of 20.00 and a low estimate of 8.00. The median estimate represents a +121.84% increase from the last price of 5.86.
The current consensus among 5 polled investment analysts is to Buy stock in Milestone Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.36
Reporting Date Mar 11
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.